2024
DOI: 10.1038/s41584-023-01065-6
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances and evolving concepts in Still’s disease

Piero Ruscitti,
Luca Cantarini,
Peter A. Nigrovic
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 259 publications
0
4
0
Order By: Relevance
“…It has been observed that initiating this class of drugs early is more effective and leads to a more enduring response. In refractory cases and in the development of HLH, Janus kinase inhibitors as well as interferon-gamma inhibitors are also considered [7]. Furthermore, the efficacy of canakinumab therapy on patients with sJIA, both clinically and in the laboratory, was demonstrated in clinical trials, where gene expression analysis was conducted three days after drug administration.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It has been observed that initiating this class of drugs early is more effective and leads to a more enduring response. In refractory cases and in the development of HLH, Janus kinase inhibitors as well as interferon-gamma inhibitors are also considered [7]. Furthermore, the efficacy of canakinumab therapy on patients with sJIA, both clinically and in the laboratory, was demonstrated in clinical trials, where gene expression analysis was conducted three days after drug administration.…”
Section: Discussionmentioning
confidence: 99%
“…The etiology remains unknown, and the pathogenesis, considered a possible mixed (autoinflammatory > autoimmune) systemic inflammatory disease, involves the dysregulation of both the innate and adaptive immune systems [7]. On the one hand, gathered data suggest dysregulation within the innate immune system, reflecting the autoinflammatory nature of the disease, characterized by the activation of interleukin-1 beta (IL-1β) and interferon-gamma (IFN-γ) signaling pathways [8].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…NK cells also demonstrate enrichment of proinflammatory pathways, reduced expression of immunomodulatory genes, and impaired cytotoxic functions. Furthermore, the compromised killing activity of NK cells may contribute to extensive activation and expansion of cytotoxic CD8 T lymphocytes, production of IFNγ and other macrophage activating factors, which in turn stimulate macrophages for prolonged periods, resulting in excessive activation and expansion of macrophages that induce the onset and progression of JIA through heightened inflammatory immune activation ( 28 ). Moreover, another study observed abnormal changes in NK cells following the same single-cell data analysis of POF ( 29 ); it can be inferred that these abnormal changes in NK cells predispose individuals to long-term inflammation, potentially contributing to ovarian dysfunction and diminished ovarian reserve.…”
Section: Discussionmentioning
confidence: 99%